PMV Pharmaceuticals develops oral small molecule cancer drugs that target mutations in the p53 protein. It last closed at $0.88 on Nov 20, down 33.13% on the day. The next earnings report for PMVP is expected around Fri, Mar 5, 2027. For the quarter ended Sep 2026, PMVP reported EPS of -$0.52. Over its last 8 reports the stock moved an average of 3.8% the session after earnings.
AI Auto Pilots
Is PMVP in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PMVP.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PMVPStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PMVP · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 43% below its 20 day and 56% below its 50 day average. It is 50% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 31), near oversold. The nearest support is the 52 week low at $0.66, and the nearest resistance the Pivot at $0.96.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 16.8%/day
Key levels
$1.9152 week high+117.0%
$1.3750 day average+55.7%
$1.31100 day average+48.9%
$1.31200 day average+48.9%
$1.28Swing high (Jun 2)+45.5%
$1.26Pivot R1+43.2%
$1.2520 day average+42.0%
$0.96Pivot+9.1%
$0.88Last close
$0.6652 week low−25.0%
$0.58Pivot S1−34.1%
Indicators
RSI (14)
31.45
Weak, oversold below 30
Neutral
MACD
-0.06
Below its signal line
Bearish
Stochastic
44.4
Middle of its range
Neutral
ADX (14)
24.7
Weak trend
Williams %R
-72.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-321.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−30.5%
Change over 10 sessions
Bearish
ATR (14)
$0.15
Typical daily range, 16.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 29.5%/day
Key levels
$1.9152 week high+117.0%
$1.3750 day average+55.7%
$1.31100 day average+48.9%
$1.31200 day average+48.9%
$1.28Swing high (Jun 2)+45.5%
$1.26Pivot R1+43.2%
$1.2520 day average+42.0%
$0.96Pivot+9.1%
$0.88Last close
$0.6652 week low−25.0%
$0.58Pivot S1−34.1%
Indicators
RSI (14)
38.08
Weak, oversold below 30
Neutral
MACD
-0.03
Below its signal line
Bearish
Stochastic
21.2
Middle of its range
Neutral
ADX (14)
15.7
No clear trend
Williams %R
-82.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-226.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−37.4%
Change over 10 sessions
Bearish
ATR (14)
$0.26
Typical daily range, 29.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for PMVP
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PMVP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PMVP usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PMVPHow many large options trades hit PMVP, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PMVP in the last 90 days.
From SEC Form 4 filings by PMVP's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PMVP is in one of them and how their past PMVP trades turned out.
PMV Pharmaceuticals is a cancer drug developer based in Princeton, New Jersey. It develops oral small molecule medicines that aim to restore normal function to mutant p53, a protein that helps stop cancer growth when it works properly. Its lead product candidate, rezatapopt, targets a specific p53 mutation found in several solid tumors, including some ovarian, lung and colorectal cancers. The company's therapies are intended for cancer patients whose tumors carry these mutations.